Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria A Joshi

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The Oncologist|February 9, 2007
Response to treatment and survival of patients with non-small cell lung cancer undergoing somatic EGFR mutation testingLecia V Sequist, Victoria A Joshi, Pasi A Jänne, et al.
The Journal of Molecular Diagnostics : JMD|June 27, 2007
Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar featuresKarin E Finberg, Lecia V Sequist, Victoria A Joshi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2012
The introduction of systematic genomic testing for patients with non-small-cell lung cancerStephanie Cardarella, Taylor M Ortiz, Victoria A Joshi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2012
The impact of initial gefitinib or erlotinib versus chemotherapy on central nervous system progression in advanced non-small cell lung cancer with EGFR mutationsStephanie Heon, Beow Y Yeap, Neal I Lindeman, et al.
Nature Genetics|December 5, 2006
Germline gain-of-function mutations in SOS1 cause Noonan syndromeAmy E Roberts, Toshiyuki Araki, Kenneth D Swanson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screeningPasi A Jänne, Ana M Borras, Yanan Kuang, et al.
JAMA Oncology|June 19, 2015
Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family RegistryMatthew B Yurgelun, Serena Masciari, Victoria A Joshi, et al.
Human Mutation|March 25, 2011
The GeneInsight Suite: a platform to support laboratory and provider use of DNA-based genetic testingSamuel J Aronson, Eugene H Clark, Lawrence J Babb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinibDavid M Jackman, Beow Y Yeap, Lecia V Sequist, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Epidermal growth factor receptor mutation testing in the care of lung cancer patientsLecia V Sequist, Victoria A Joshi, Pasi A Jänne, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Oncologist|February 9, 2007
Response to treatment and survival of patients with non-small cell lung cancer undergoing somatic EGFR mutation testingLecia V Sequist, Victoria A Joshi, Pasi A Jänne, et al.
The Journal of Molecular Diagnostics : JMD|June 27, 2007
Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar featuresKarin E Finberg, Lecia V Sequist, Victoria A Joshi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2012
The introduction of systematic genomic testing for patients with non-small-cell lung cancerStephanie Cardarella, Taylor M Ortiz, Victoria A Joshi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2012
The impact of initial gefitinib or erlotinib versus chemotherapy on central nervous system progression in advanced non-small cell lung cancer with EGFR mutationsStephanie Heon, Beow Y Yeap, Neal I Lindeman, et al.
Nature Genetics|December 5, 2006
Germline gain-of-function mutations in SOS1 cause Noonan syndromeAmy E Roberts, Toshiyuki Araki, Kenneth D Swanson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screeningPasi A Jänne, Ana M Borras, Yanan Kuang, et al.
JAMA Oncology|June 19, 2015
Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family RegistryMatthew B Yurgelun, Serena Masciari, Victoria A Joshi, et al.
Human Mutation|March 25, 2011
The GeneInsight Suite: a platform to support laboratory and provider use of DNA-based genetic testingSamuel J Aronson, Eugene H Clark, Lawrence J Babb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinibDavid M Jackman, Beow Y Yeap, Lecia V Sequist, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Epidermal growth factor receptor mutation testing in the care of lung cancer patientsLecia V Sequist, Victoria A Joshi, Pasi A Jänne, et al.
Pageof 3